“Production of modern innovative drugs today is not only risky in terms of return on investment, but also costly in terms of its output on the market with accordance to all mandatory regulations and rules. Often, these expenses are too high for one company and we see a lot of merger and accession on the market,” said ARPM Director General, Victor Dmitriev at the congress “Rational pharmacotherapy” ...
Russian pharma showed its great potential at the 27th international pharmaceutical exhibition CPhI. The Russia industry was represented by entrepreneurs and regulators. The section of the Ministry of Industry and Trade presented Russian companies that are developing their export. ARPM Director General, Victor Dmitriev gave a presentation on the first results of the Federal program of “Development of the medical and pharmaceutical industry by 2020”.
The 7th conference “Current situation on the pharmaceutical market” took place in Moscow. The event’s agenda on price formation and compulsory licensing were moderated by ARPM deputy director, Elena Maslovskaya and Advisor to the law firm "Egorov, Puginsky, Afanasiev and Partners" Denis Gavrilov.
CT-1 certificates and other new regulations were the agenda of the Partnering conference in Kazan22 September 2016Beginning 09-00KazanThe Fourth Partnering “Russian Medicine. An interdisciplinary dialogue” took place in Kazan. This annual event, hosted by the Federal Antimonopoly Service, Health Ministry of Kazan, and the Association of the Russian Pharmaceutical Manufacturers, brought together over 200 people, of which representatives of industry companies, and state agencies.